Volunteers Reshape Chapter for COVID-19

Posted by ISPE Boston
On September 3, 2020

No live presentations? No indoor gatherings? No problem! Our volunteers deserve a special thank you this year for taking the pandemic in stride and adapting the Chapter’s activities to fit the new reality. No one says it better than outgoing Chapter President Eric Felz who praised the Chapter’s volunteers for rising to the challenge and […]

Abbott’s Rapid Covid-19 Test to Create 1200 Jobs in Maine

Posted by ISPE Boston
On September 3, 2020

The FDA has issued Emergency Use Authorization (EUA) for Abbott’s BinaxNOW rapid antigen test for detection of COVID-19 infection. The $5 test is highly portable, affordable and provides results in 15 minutes. It uses proven Abbott lateral flow technology, making it a reliable and familiar format for frequent mass testing by healthcare providers. Abbott will ship […]

Takeda to Sell Consumer Health Care Business for 2.3 Billion, Focus on Innovative Medicines

Posted by ISPE Boston
On September 3, 2020

Takeda has entered into an agreement to divest Takeda Consumer Healthcare Company (TCHC), a wholly-owned subsidiary of Takeda focused on the consumer health care market primarily in Japan, to a company controlled by funds managed by The Blackstone Group for a total value of 2.3 billion USD. The transaction is expected to close by March […]

Foundation Medicine Liquid Biopsy Gets FDA Okay

Posted by ISPE Boston
On September 3, 2020

The FDA has approved Foundation Medicine’s comprehensive pan-tumor liquid biopsy test, Called FoundationOne Liquid CDx. Using a blood sample, the test analyzes over 300 cancer-related genes for alterations. Results are delivered in an integrated report that identifies alterations matched to FDA-approved therapies and delivers information about the genomic signatures microsatellite instability and blood tumor mutational […]

Scholarship Winners for 2020: In Their Own Words

Posted by ISPE Boston
On August 27, 2020

Chemical engineering, biotechnology and engineering management – these are the fields of study chosen by the winners of the 2020 Joel Goldenberg Memorial Scholarships recently awarded by the Boston Area Chapter Scholarship Foundation. The impact of these awards is best expressed by the three winners themselves, all of whom are planning careers in our industry […]

Thoughts on Careers in Biopharm (and More) from Our Scholarship Winners

Posted by ISPE Boston
On August 27, 2020

Congratulations to 2020 Joel Goldenberg Memorial Scholarship winners Maggie Cai, Mark DeSimone and Emma Sinkus, all of whom are planning careers in our industry and excel in both academics and service to the community. We asked them to share their thoughts about winning the scholarships, their future career plans, our industry and the pandemic: Maggie […]

Momenta to be Acquired by J&J for $6.5 Billion

Posted by ISPE Boston
On August 20, 2020

Momenta Pharmaceuticals has agreed to be acquired by Johnson & Johnson for $52.50 per share in an all-cash transaction, implying a fully-diluted equity value of $6.5 billion. The agreement was unanimously approved by the Boards of Directors of both Momenta and Johnson & Johnson. “The agreement with J&J recognizes the value created by years of […]

Sanofi to Acquire Principia for $3.6 Billion

Posted by ISPE Boston
On August 20, 2020

Sanofi and San Francisco-based Principia Biopharma have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of approximately $3.68 billion (on a fully diluted basis). Principia Biopharma is a late-stage biopharma focused on developing treatments […]

Tango and Gilead to Expand Collaboration

Posted by ISPE Boston
On August 20, 2020

Gilead Sciences and Cambridge-based Tango Therapeutics have announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies for patients with cancer. Under the expanded multi-year collaboration, which builds on an agreement signed in 2018, Tango will continue to leverage its proprietary, CRISPR-enabled functional genomics target discovery platform […]

Industry Veterans Provide Career Insights

Posted by ISPE Boston
On August 19, 2020

Interested in advice from respected industry professionals on how to achieve your career goals and navigate unexpected career turns? Then we’re sure you tuned in for the Chapter’s first career development “fireside chat” when Haroon Hashmi of Ziopharm Oncology and Jane Rhodes of Verge Genomics settled in for a virtual Q & A with moderator […]

Page 52 of 90«‹50 515253 54 ›»